Product Information
REPAGLINIDE 2 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.0917 per EA under NDC 62135094890. Its NADAC has been published 29 times since Dec 10, 2025.
Strength
2 mg/1
Manufacturer
Chartwell RX LLCNDC
62135094890
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
REPAGLINIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078555On Market Since
1/22/2014
Pharmacological Classes
Price Statistics
The NADAC for REPAGLINIDE 2 MG TABLET has been published 29 times since Dec 10, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0917 per EA |
|---|---|
| All-time high | $0.0966 (Jan 14, 2026) |
| All-time low | $0.0859 (Mar 18, 2026) |
| 52-week high | $0.0966 |
| 52-week low | $0.0859 |
| Median price | $0.0894 |
| Average price | $0.0903 |
| Largest weekly change | +6.2% (Dec 17, 2025) |
| Weeks tracked | 29 |
| Tracking since | Dec 10, 2025 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of REPAGLINIDE 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for REPAGLINIDE 2 MG TABLET, manufactured by Chartwell RX LLC, is $0.0917 per EA (NDC 62135094890), effective Jun 24, 2026.
How has the price of REPAGLINIDE 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for REPAGLINIDE 2 MG TABLET has held within roughly two percent of its current level. It has been tracked across 29 weekly CMS publications since Dec 10, 2025.
What are the highest and lowest recorded NADAC prices for REPAGLINIDE 2 MG TABLET?
Since Dec 10, 2025, the NADAC for REPAGLINIDE 2 MG TABLET has ranged from a low of $0.0859 (Mar 18, 2026) to a high of $0.0966 (Jan 14, 2026), with a median of $0.0894 per EA.
Are there cheaper alternatives to REPAGLINIDE 2 MG TABLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as REPAGLINIDE 2 MG TABLET, but none are currently priced below it.
Who manufactures REPAGLINIDE 2 MG TABLET?
REPAGLINIDE 2 MG TABLET (NDC 62135094890) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification